Psoriasis

The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.

Latest News

Plaque psoriasis | Image credit: Milan Lipowski - stock.adobe.com
Defining On-Treatment Remission in Plaque Psoriasis

June 18th 2025

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

Adalimumab | Image credit: luchschenF - stock.adobe.com
Methotrexate Adds No Benefit to Adalimumab in Psoriasis Treatment, Study Suggests

June 16th 2025

Psoriasis | Image credit: SergeVo - stock.adobe.com
Low BSA in Psoriasis May Still Mean High Disease Burden

June 12th 2025

Psoriasis skin, eczema, rash and other skin diseases. | Image credit: stockmaster - stock.adobe.com.jpg
Patients With GPP Face Elevated Mortality Risk, Study Finds

June 3rd 2025

woman with psoriasis | Image credit: Andrey Popov - stock.adobe.com
Biosimilar Starjemza Gains FDA Approval as Ustekinumab Shows Significant Psoriasis-Itch Relief

May 29th 2025

A Personalized Approach to Disease Management in Psoriasis

A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.

Ryan Haumschild, PharmD, MS, MBA, Bhavesh Shah, PharmD, Mark Lebwohl, MD, and Robert Groves, MD.
Continuing Medical Education
View All
June 30th 2025

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
June 30th 2025

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology
June 30th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 30th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Site Logo
October 2nd 2016

Emerging Therapies and Future Considerations for Treating Moderate-to-Severe Atopic Dermatitis

The 4-part lecture, “Practical Application of Novel Targeted Strategies in Moderate-to-Severe Atopic Dermatitis” covered the pathogenesis of atopic dermatitis (AD), new insights into the pathophysiology in AD, considerations for change in the treatment of AD, and the latest developments in treatment.
Site Logo
July 6th 2016

Easing the Economic and Clinical Burden of Psoriasis and Psoriatic Arthritis: The Role of Managed Care

Site Logo
June 20th 2016

Psoriasis and Psoriatic Arthritis Treatment

Alan Menter, MD
Over the past several years, an increased understanding of the pathophysiology of psoriasis and psoriatic arthritis has led to the development of several new biologic therapies.
Site Logo
June 17th 2016

Psoriasis and Psoriatic Arthritis Overview

Alan Menter, MD
Site Logo
March 18th 2016

National Psoriasis Foundation: A Patient-Centric Approach to Improve Access to Psoriatic Disease Treatment

Leah McCormick Howard, JD
This case study from the National Psoriasis Foundation describes its aim to eliminate access barriers-including cost-through legislative and regulatory advocacy, direct patient assistance programs, and engagement with health insurers.
Site Logo
October 11th 2013

Express Scripts Stops Covering Key Big Pharma Drugs on Clinical, Cost-Effectiveness Grounds

A few weeks ago, Novo Nordisk ($NVO) said it had lost Express Scripts' business on two of its top drugs, Victoza and NovoLog. Well, that was just part of the action at the pharmacy benefits manager.
<1
...
1112131415

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo